Acadia Healthcare (NASDAQ:ACHC) Given New $28.00 Price Target at UBS Group

Acadia Healthcare (NASDAQ:ACHC) had its price target lowered by UBS Group from $31.00 to $28.00 in a research report released on Friday,Benzinga reports. UBS Group currently has a buy rating on the stock.

ACHC has been the subject of several other reports. Raymond James Financial set a $22.00 price target on shares of Acadia Healthcare in a report on Friday. Royal Bank Of Canada reduced their price target on Acadia Healthcare from $43.00 to $28.00 and set an “outperform” rating for the company in a report on Wednesday, August 13th. KeyCorp decreased their price target on Acadia Healthcare from $55.00 to $35.00 and set an “overweight” rating on the stock in a research note on Wednesday, October 8th. Cowen reiterated a “buy” rating on shares of Acadia Healthcare in a research report on Thursday, August 7th. Finally, Barclays decreased their target price on shares of Acadia Healthcare from $20.00 to $17.00 and set an “equal weight” rating on the stock in a research report on Thursday. Eight equities research analysts have rated the stock with a Buy rating, five have assigned a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $33.55.

Acadia Healthcare Stock Performance

Shares of Acadia Healthcare stock traded down $0.75 during trading hours on Friday, hitting $19.51. 3,669,338 shares of the company were exchanged, compared to its average volume of 2,371,025. The company has a current ratio of 1.32, a quick ratio of 1.32 and a debt-to-equity ratio of 0.73. The business has a 50-day moving average of $23.34 and a 200-day moving average of $22.78. Acadia Healthcare has a 1 year low of $17.13 and a 1 year high of $47.08. The stock has a market capitalization of $1.80 billion, a price-to-earnings ratio of 12.92, a P/E/G ratio of 4.56 and a beta of 0.97.

Acadia Healthcare (NASDAQ:ACHC) last announced its quarterly earnings data on Wednesday, November 5th. The company reported $0.72 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.71 by $0.01. Acadia Healthcare had a net margin of 4.31% and a return on equity of 8.34%. The company had revenue of $851.57 million for the quarter, compared to analysts’ expectations of $852.43 million. During the same period in the previous year, the company posted $0.91 EPS. Acadia Healthcare’s revenue was up 4.4% compared to the same quarter last year. Acadia Healthcare has set its FY 2025 guidance at 2.350-2.450 EPS. As a group, analysts expect that Acadia Healthcare will post 3.38 EPS for the current fiscal year.

Institutional Inflows and Outflows

Institutional investors have recently modified their holdings of the stock. Teacher Retirement System of Texas acquired a new stake in Acadia Healthcare during the 1st quarter valued at $412,000. Envestnet Asset Management Inc. boosted its stake in shares of Acadia Healthcare by 8.2% during the first quarter. Envestnet Asset Management Inc. now owns 108,238 shares of the company’s stock valued at $3,282,000 after acquiring an additional 8,222 shares during the last quarter. New York State Common Retirement Fund increased its position in Acadia Healthcare by 2.5% during the 1st quarter. New York State Common Retirement Fund now owns 232,582 shares of the company’s stock worth $7,052,000 after purchasing an additional 5,775 shares in the last quarter. Edgestream Partners L.P. raised its stake in Acadia Healthcare by 20.8% in the 1st quarter. Edgestream Partners L.P. now owns 108,708 shares of the company’s stock valued at $3,296,000 after purchasing an additional 18,682 shares during the last quarter. Finally, Victory Capital Management Inc. lifted its holdings in Acadia Healthcare by 11.9% in the 1st quarter. Victory Capital Management Inc. now owns 19,379 shares of the company’s stock valued at $588,000 after purchasing an additional 2,065 shares in the last quarter.

About Acadia Healthcare

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.